The Benefits

Are you ready for Straumann® Emdogain™ to help you grow your practice?  How are you eliminating treatment barriers for your patients?
True Regeneration – CLINICAL Benefits
  • True regeneration of the underlying support structures for the gingiva1,2
  • Improved clinical attachment level gain*3
  • Designed for predictable results
Practice Growth – BUSINESS Benefits
  • Helps position you as a clinician who offers excellent long term options and results4
  • Creates new treatment opportunities and revenue stream
  • Creates value to your GPs and your patients
Function and Esthetics – PATIENT Benefits
  • Produces a natural-looking result5
  • Helps restore patients‘ self-confidence and preserve their smile
  • Enhanced periodontal wound healing as reported by clinicians
  • Less pain and discomfort**5

* Compared to CAF alone
**  Compared to CTG

1 McGuire, MK & Nunn, M. Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue. Part 2: Histologic evaluation. J Periodontol 2003;74:1126-1135.
2 Rasperini G, et al. Clinical and histologic evaluation of human gingival recession treated with a subepithelial connective tissue graft and enamel matrix derivative (Emdogain): a case report.Int J Periodontics Restorative Dent. 2000;20:269-275.
3 Cairo F, Pagliaro U, Nieri M. Treatment of gingival recession with coronally advanced flap procedures: a systematic review. J Clin Periodontol 2008;35(Suppl 8):136-162.
4 McGuire MK, Scheter ET, Nunn M. Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue: Comparison of clinical parameters at ten years. J Periodontol. 2012 [ Epub ahead of print]
5  McGuire, MK & Nunn, M. Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue. Part 1: Comparison of clinical parameters. J Periodontol 2003;74:1110-1125